series-a
Stage
1
Investors
About
EyeBio develops AI-powered solutions for early diagnosis and monitoring of eye diseases based on biometric data analysis.
Explore EyeBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.